Terms: = Liver cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Treatment
845 results:
1. Probiotic-derived silver nanoparticles target mtor/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment.
Elmetwalli A; Abdel-Monem MO; El-Far AH; Ghaith GS; Albalawi NAN; Hassan J; Ismail NF; El-Sewedy T; Alnamshan MM; ALaqeel NK; Al-Dhuayan IS; Hassan MG
Med Oncol; 2024 Apr; 41(5):106. PubMed ID: 38575697
[TBL] [Abstract] [Full Text] [Related]
2.
Miao X; Jiang P; Zhang X; Li X; Wu Z; Jiang Y; Liu H; Xie W; Li X; Shi B; Cai J; Gong W
Microbiol Spectr; 2024 May; 12(5):e0183923. PubMed ID: 38564670
[TBL] [Abstract] [Full Text] [Related]
3. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mtor/MAPK pathways in hepatocellular carcinoma cells.
Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
[TBL] [Abstract] [Full Text] [Related]
4. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells.
Chaisupasakul P; Pekthong D; Wangteeraprasert A; Kaewkong W; Somran J; Kaewpaeng N; Parhira S; Srisawang P
PLoS One; 2024; 19(3):e0300051. PubMed ID: 38527038
[TBL] [Abstract] [Full Text] [Related]
5. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
[TBL] [Abstract] [Full Text] [Related]
6. Everolimus decreases [U-
Ariaans G; Tiersma JF; Evers B; Gerding A; Waaijer SJH; Koster RA; Touw DJ; Bakker BM; Reijngoud DJ; de Jong S; Jalving M
Biomed Pharmacother; 2024 Apr; 173():116362. PubMed ID: 38432130
[TBL] [Abstract] [Full Text] [Related]
7. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
8. Everolimus inhibits hepatoblastoma by inducing autophagy-dependent ferroptosis.
Huang H; Yan J; Xu X; Feng Y; Liu H; Liu J; Xie M; Chen L; Xiang D; Peng W; Zeng L; Zeng Y; Chen F; Zhang S; Liu Q
Drug Dev Res; 2024 Feb; 85(1):e22140. PubMed ID: 38349263
[TBL] [Abstract] [Full Text] [Related]
9. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract] [Full Text] [Related]
10. MHY1485 promotes adriamycin sensitivity in HepG2 cells by inhibiting autophagy.
Guo J; Lei Y; Liu L; Wen Z; Zhang B; Fang J; Liang G; Guo Q; Peng J
Funct Integr Genomics; 2024 Feb; 24(1):22. PubMed ID: 38306005
[TBL] [Abstract] [Full Text] [Related]
11. Natural products targeting macroautophagy signaling in hepatocellular carcinoma therapy: Recent evidence and perspectives.
Chen Y; Tan X; Zhang W; Li Y; Deng X; Zeng J; Huang L; Ma X
Phytother Res; 2024 Mar; 38(3):1623-1650. PubMed ID: 38302697
[TBL] [Abstract] [Full Text] [Related]
12. Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mtor pathway in hepatocellular carcinoma.
Sun Z; Liu L; Liang H; Zhang L
Mol Carcinog; 2024 Apr; 63(4):577-588. PubMed ID: 38197493
[TBL] [Abstract] [Full Text] [Related]
13. SKI-349, a Sphingosine Kinases 1/2 Inhibitor, Suppresses Cell Viability, Invasion, and AKT/mtor Signaling Pathway, and Shows Synergistic Cytotoxic Effects with Sorafenib in Hepatocellular Carcinoma.
Chen L; Wang L; Han Z; Qin P; Niu G; Du J
Tohoku J Exp Med; 2024 Mar; 262(3):173-180. PubMed ID: 38123304
[TBL] [Abstract] [Full Text] [Related]
14. Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming.
Ji X; Yang Z; Li C; Zhu S; Zhang Y; Xue F; Sun S; Fu T; Ding C; Liu Y; Wan Q
Metabolism; 2024 Mar; 152():155761. PubMed ID: 38104924
[TBL] [Abstract] [Full Text] [Related]
15. FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mtorC1 Signaling Pathway.
Wang Y; Wang G; Hu S; Yin C; Zhao P; Zhou X; Shao S; Liu R; Hu W; Liu GL; Ke W; Song Z
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069034
[TBL] [Abstract] [Full Text] [Related]
16. CRISPR screening identifies BET and mtor inhibitor synergy in cholangiocarcinoma through serine glycine one carbon.
Zhu Y; Zhang D; Shukla P; Jung YH; Malgulwar PB; Chagani S; Colic M; Benjamin S; Copland JA; Tan L; Lorenzi PL; Javle M; Huse JT; Roszik J; Hart T; Kwong LN
JCI Insight; 2024 Jan; 9(2):. PubMed ID: 38060314
[TBL] [Abstract] [Full Text] [Related]
17. TP53/mtorC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
Yu J; Ling S; Hong J; Zhang L; Zhou W; Yin L; Xu S; Que Q; Wu Y; Zhan Q; Bao J; Xu N; Liu Y; Chen K; Wei X; Liu Z; Feng T; Zhou L; Xie H; Wang S; Liu J; Zheng S; Xu X
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030304
[TBL] [Abstract] [Full Text] [Related]
18. Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate.
Deng R; Zheng Z; Hu S; Wang M; Feng J; Mattjus P; Zhang Z; Zhang Y
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119644. PubMed ID: 37996059
[TBL] [Abstract] [Full Text] [Related]
19. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
20. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
[Next]
